PARIS — Five years of follow-up in a large series of patients implanted with the iStent inject, mostly combined with cataract surgery, showed sustained IOP reduction, with 75% of eyes remaining medication-free.
At the European Society of Cataract and Refractive Surgeons meeting, Tobias Neuhann, MD, presented results of a retrospective analysis of 270 patients he personally implanted with the iStent inject (Glaukos) over 5 years. In 91% of the cases, the procedure was combined with cataract surgery.
“Results were excellent. Mean IOP at 5 years was 16 mm Hg or (Read more...)
Uncategorized